Michael D. West is CEO at AgeX Therapeutics, Inc. (AGE). They have made 5 open-market trades across 2 companies since 2011, most recently 2023-03-11.
CIK 0001202529
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $105K since 2011, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AGE | BUY | 2018-12-10 | 2018-12-12 | $3.86 | $15K | -14.9% | +58.1% | +42.2% |
| BTX | BUY | 2017-08-22 | 2017-08-23 | $2.60 | $5K | +7.4% | -0.1% | -0.1% |
| BTX | SELL | 2014-07-22 | 2014-07-23 | $2.65 | $716K | +7.4% | -0.1% | -0.1% |
| BTX | BUY | 2012-05-31 | 2012-05-31 | $4.05 | $41K | +7.4% | -0.1% | -0.1% |
| BTX | BUY | 2011-06-22 | 2011-06-23 | $4.40 | $44K | +7.4% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.